Evaluation & Technical Assistance Center (ETAC)
Research Publications
- Addressing Coinfection with Viral Hepatitis
- Viral Hepatitis Updates from CDC
- The Economic Burden of Hepatitis C-Associated Diseases
- Updated Boceprevir (Victrelis) Label Adds Data on Prior Null Responders
- Severe Stomatitis Complicating Treatment With Pegylated-Interferon and Ribavirin in an HCV-Infected Patient
- New Agents for the Treatment of Hepatitis C Virus — Focus on Telaprevir
- Acute Hepatitis C Infection in HIV-Positive Patients
- IL28B Polymorphism Improves Viral Kinetics and is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus
- IL28B Genomic-Based Treatment Paradigms for Patients with Chronic Hepatitis C Infection: The Future of Personalized HCV Therapies
- Genetic Variation in IL28B: Impact on Drug Development for Chronic Hepatitis C Infection
- A Clinician's Guide To HIV and Hepatitis A,B,C
- A Guide for Evaluation and Treamtent of Hepatitis C in Adults Co-infected with HIV
- A New Era of Hepatitis C Therapy Begins
- Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
- Hepatitis A and B Immunization in Persons Infected with HIV
- Hepatitis C in HIV Infected Patients 101
- Treatment Initiation and Monitoring in HIV/HCV Co-infected Patients
- PEG-IFN Induced Interstitial Pneumonitis in Hepatitis C
- Ocular Complications of PEG-Interferon
- FDA Grants Waiver for OraQuick HCV Rapid Test